The Optimal Time for Initiating Probiotics for Preterm and Very-Low-Birth-Weight Infants: A 10-Year Experience in a Single Neonatal Intensive Care Unit
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The starting time for probiotic supplementation in preterm infants after birth varies widely. This study aimed to investigate the optimal time for initiating probiotics to reduce adverse outcomes in preterm or very low birth weight (VLBW) infants. Methods: Medical records of preterm infants born at a gestational age (GA) of <32 weeks or VLBW infants in 2011–2020 were reviewed respectively. The infants who received Saccharomyces boulardii probiotics within 7 days of birth were grouped into an early introduction (EI) group, and those who received supplemented probiotics after 7 days of birth were part of the late introduction (LI) group. Clinical characteristics were compared between the two groups and analyzed statistically. Results: A total of 370 infants were included. The mean GA (29.1 weeks vs. 31.2 weeks, p<0.001) and birth weight (1,235.9 g vs. 1491.4 g, p<0.001) were lower in the LI group (n=223) than in the EI group. The multivariate analysis indicated that factors affecting the LI of probiotics were GA at birth (odds ratio [OR], 1.52; p<0.001) and the enteral nutrition start day (OR, 1.47; p<0.001). The late probiotic introduction was associated with a risk of late-onset sepsis (OR, 2.85; p=0.020), delayed full enteral nutrition (OR, 5.44; p<0.001), and extrauterine growth restriction (OR, 1.67; p=0.033) on multivariate analyses after adjusting for GA. Conclusion: Early supplementation of probiotics within a week after birth may reduce adverse outcomes among preterm or VLBW infants.
Abstract
Purpose: The starting time for probiotic supplementation in preterm infants after birth varies widely. This study aimed to investigate the optimal time for initiating probiotics to reduce adverse outcomes in preterm or very low birth weight (VLBW) infants. Methods: Medical records of preterm infants born at a gestational age (GA) of <32 weeks or VLBW infants in 2011–2020 were reviewed respectively. The infants who received Saccharomyces boulardii probiotics within 7 days of birth were grouped into an early introduction (EI) group, and those who received supplemented probiotics after 7 days of birth were part of the late introduction (LI) group. Clinical characteristics were compared between the two groups and analyzed statistically. Results: A total of 370 infants were included. The mean GA (29.1 weeks vs. 31.2 weeks, p<0.001) and birth weight (1,235.9 g vs. 1491.4 g, p<0.001) were lower in the LI group (n=223) than in the EI group. The multivariate analysis indicated that factors affecting the LI of probiotics were GA at birth (odds ratio [OR], 1.52; p<0.001) and the enteral nutrition start day (OR, 1.47; p<0.001). The late probiotic introduction was associated with a risk of late-onset sepsis (OR, 2.85; p=0.020), delayed full enteral nutrition (OR, 5.44; p<0.001), and extrauterine growth restriction (OR, 1.67; p=0.033) on multivariate analyses after adjusting for GA. Conclusion: Early supplementation of probiotics within a week after birth may reduce adverse outcomes among preterm or VLBW infants.
참고문헌 (24)
- Cong X, "Early life experience and gut microbiome : the brain-gut-microbiota signaling system", Adv Neonatal Care, 15, pp.314~323 (2015)
- Keunen K, "Impact of nutrition on brain development and its neuroprotective implications following preterm birth", Pediatr Res, 77, pp.148~155 (2015)
- Costeloe K, "Bifidobacterium breve BBG-001 in very preterm infants : a randomised controlled phase 3 trial", Lancet, 387, pp.649~660 (2016)
- Chi C, "Effects of a formula with a probiotic Bifidobacterium lactis Supplement on the gut microbiota of low birth weight infants", Eur J Nutr, 59, pp.1493~1503 (2020)
- van den Akker CHP, "Probiotics and preterm infants : a position paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics", J Pediatr Gastroenterol Nutr, 70, pp.664~680 (2020)
- Morgan RL, "McMaster Probiotic, Prebiotic, and Synbiotic Work Group. Probiotics reduce mortality and morbidity in preterm, low-birth-weight infants : a systematic review and network meta-analysis of randomized trials", Gastroenterology, 159, pp.467~480 (2020)
- Gibbons J, "A pilot study to establish an in vitro model to study premature intestinal epithelium and gut microbiota interactions", mSphere, 6, pp.e0080621~ (2021)
- Plaza-Díaz J, "Human milk oligosaccharides and immune system development", Nutrients, 10, pp.1038~ (2018)
- Brooks B, "The developing premature infant gut microbiome is a major factor shaping the microbiome of neonatal intensive care unit rooms", Microbiome, 6, pp.112~ (2018)
- Chi C, "Longitudinal gut bacterial colonization and its influencing factors of low birth weight infants during the first 3 months of life", Front Microbiol, 10, pp.1105~ (2019)
- Athalye-Jape G, "Probiotics for preterm infants-time to end all controversies", Microb Biotechnol, 12, pp.249~253 (2019)
- Barbian ME, "To start or not : factors to consider when implementing routine probiotic use in the NICU", Early Hum Dev, 135, pp.66~71 (2019)
- Chou JH, "PediTools electronic growth chart calculators : applications in clinical care, research, and quality improvement", J Med Internet Res, 22, pp.e16204~ (2020)
- Kawai M, "Late-onset circulatory collapse of prematurity", Pediatr Int, 59, pp.391~396 (2017)
- Jobe AH, "Bronchopulmonary dysplasia", Am J Respir Crit Care Med, 163, pp.1723~1729 (2001)
- Deshpande GC, "Evidence-based guidelines for use of probiotics in preterm neonates", BMC Med, 9, pp.92~ (2011)
- Costalos C, "Enteral feeding of premature infants with Saccharomyces boulardii", Early Hum Dev, 74, pp.89~96 (2003)
- Mohan R, "Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants : a double-blind, placebo-controlled, randomized study", J Clin Microbiol, 44, pp.4025~4031 (2006)
- Fernández-Carrocera LA, "Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis", Arch Dis Child Fetal Neonatal Ed, 98, pp.F5~F9 (2013)
- Mihatsch WA, "Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants : a randomized controlled trial", Neonatology, 98, pp.156~163 (2010)
- Demirel G, "Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants : a randomized, controlled study", Acta Paediatr, 102, pp.e560~e565 (2013)
- Xu L, "A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants", J Pediatr(Rio J), 92, pp.296~301 (2016)
- Rannikko J, "Fungemia and other fungal infections associated with use of Saccharomyces boulardii probiotic supplements", Emerg Infect Dis, 27, pp.2090~2096 (2021)
- Atıcı S, "Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment : in a child in intensive care unit and review of the literature", Med Mycol Case Rep, 15, pp.33~35 (2017)